I'll research CTAS (Cintas) before writing the preview. Let me gather recent filings, transcripts, news, and price data.Let me read the most recent Q3 earnings materials and the prior Q4 (year-ago) release for context.I have rich Q3 detail. Now let me get the year-ago Q4 numbers (for the comp), recent stock prices, and any recent news on CTAS/UniFirst.Let me get recent news and the UniFirst deal terms for context.I have enough to write a thorough preview. Let me quickly confirm the deal synergy figure.Let me pull Q1 and Q2 FY26 actuals to derive the implied Q4 setup.I now have everything I need. Here's the earnings preview.

Cintas (CTAS) — FQ4'26 Earnings Preview

Reports Wednesday, July 15, 2026 (before market open) · Fiscal Q4 ended May 31, 2026 · Call 10:00am ET

The one-line setup

Cintas closes out fiscal 2026 having beaten-and-raised guidance in each of the first three quarters. Q4 is the "prove it" quarter against the toughest comp of the year, and — more importantly — it's the print where management typically issues initial FY2027 guidance, which this year is complicated by the pending $5.5B UniFirst acquisition. Expect the forward guide and deal/integration commentary to matter more to the stock than the Q4 beat itself.

What the quarter needs to show (the implied Q4 bar)

Management raised full-year guidance at Q3 (March 25) to revenue of $11.21–$11.24B (+8.4%–8.7%) and adjusted diluted EPS of $4.86–$4.90 (+10.5%–11.4%), where "adjusted" excludes UniFirst deal costs. Backing out the first nine months implies the following Q4 targets:

Metric	FQ4'26 implied (from guide)	FQ4'25 actual (comp)	Implied Y/Y
Revenue	~$2.86–$2.89B	$2.668B	~+7–8%
Organic growth	~7.6% (per mgmt)	9.0%	decel vs. comp
Adj. diluted EPS	~$1.21–$1.25	$1.09	~+11–15%
UniFirst transaction costs	$0.03–$0.04 (new separate line)	—	—

Key comp warning management flagged: FQ4'25 was Cintas's strongest organic quarter of last year (9.0%), boosted by a one-time spike in First Aid AED training (18.5% organic) and a lumpy-strong Uniform Direct Sale quarter — neither of which is expected to repeat. So a lower headline organic rate in Q4 is by design, not deterioration. Also note Q4 carries a $0.03–$0.04 EPS drag from UniFirst transaction costs, now broken out on a separate income-statement line, so GAAP EPS (~$1.17–$1.22) will look optically softer than adjusted.

FY26 full-year context: vs. FY25's $10.34B revenue / $4.40 EPS, the FY26 guide implies ~8.5% revenue growth and ~11% adjusted EPS growth. Given Cintas raised the guide three straight quarters (initial July 2025 guide was $11.00–$11.15B / $4.71–$4.85), a modest final beat is the base case; the debate is whether the beat is large enough to matter given the stock's derating.

The three things that actually move the stock on this print

1. Initial FY2027 guidance — and how UniFirst is (or isn't) treated. This is the crux. Cintas normally frames the next fiscal year on the Q4 call. Two wrinkles this year: - UniFirst is expected to close in 2H calendar 2026 (i.e., mid-FY27). Watch whether the initial FY27 guide is organic/standalone or attempts to embed a partial-year UniFirst contribution + deal costs. Management may guide standalone and update post-close, which could create a messy "headline vs. reality" setup. - Fire ERP (SAP) headwind: management reiterated a ~100 bps margin headwind to the Fire segment in FY27 from the SAP rollout (less than 100 bps if not fully live by June 1). Not huge at the consolidated level, but a talking point for margin bears.

2. UniFirst deal progress. Announced March 11, 2026: $310.00/share, ~$5.5B enterprise value (~8x TTM run-rate EBITDA), ~$375M of operating cost synergies over ~4 years, ~1.5x net leverage at close. Management has explicitly said it will not comment on the regulatory/shareholder-vote process to avoid speculation — so don't expect much beyond "on track, closing 2H CY26." Any deviation (regulatory friction in the US/Canada, timeline slip) would be the surprise. UNF trades around $275 vs. the $310 offer, implying the market still prices meaningful deal-completion/timing risk.

3. Buyback resumption. Cintas was restricted from repurchasing during Q3 (quiet period around deal negotiation) and remains restricted from signing through the UniFirst shareholder vote. It returned $1.45B to shareholders through 9M FY26 but bought back very little recently. Commentary on when buybacks resume — and capital-allocation priorities with leverage rising to ~1.5x at close — is a swing factor for the EPS algorithm.

Fundamental trends going in (all healthy)

Segment organic growth (Q3): Uniform Rental & Facility Services +7.3%, First Aid & Safety +14.6%, Fire Protection +10%, Uniform Direct Sale +3.1%.
Margins at record highs: consolidated gross margin hit 51.0% in Q3 (+40 bps), with all-time highs in each route-based segment (Rental 50.3%, First Aid 58.1%, Fire 50.5%). Incrementals ran ~28% (adjusted), squarely in the company's target zone. Watch whether Q4 sustains the >50% gross-margin cadence.
Growth algorithm intact: retention ~95% (record), pricing 2–3% (normalized, no longer a tailwind), and ~2/3 of new business from "no-programmers" (first-time outsourcers) — the structural white-space story management leans on (16–20M businesses in North America; ~1M current customers; ~$10K average customer spend).
Demand resilience: management characterizes the macro as "complex" but the customer base as resilient. Wearer/employment levels are soft (a watch item — soft job growth caps organic upside), but the four verticals (healthcare, hospitality, education, state & local government) are holding up.

Cost/margin watch items

Fuel/energy: ~1.7% of revenue in Q3; only ~60% is vehicle fuel (~100 bps of sales). Management said a sustained ~30% fuel increase = ~30 bps of cost, already contemplated in guidance, and they run no fuel surcharge. With oil volatile, this is a modest Q4 swing factor.
Tariffs: supply chain has navigated well; management says no material near-term impact (any hit amortizes slowly through the supply chain).
SG&A optics: Q3 SG&A looked elevated but was ~flat y/y ex the prior-year one-time land-sale gain; Q3 is seasonally high on payroll-tax resets. Expect normalization commentary again.

Stock & valuation context

CTAS closed ~$184 on July 14, essentially flat YTD (started 2026 near $185) but ~10% below its early-March high of ~$205. The stock derated after the mid-March UniFirst announcement + Q3 print (it fell from ~$185 pre-announcement to ~$166 by late March) and has been range-bound $165–$185 since. It has firmed into the print (up from ~$169 in late June).
Interpretation: the market took the UniFirst deal cautiously (dilution/integration risk, buyback pause, leverage up), which has compressed CTAS's premium multiple. That sets up a lower-expectations bar than usual for a Cintas print — a clean beat + confident FY27 framing could re-rate; a cautious/complicated FY27 guide could keep it capped.

Bottom line — what I'd watch, in order

FY27 guide construction (standalone vs. UniFirst-inclusive; organic growth durability; Fire ERP margin drag).
Any UniFirst timeline/regulatory color (base case: minimal commentary, "2H CY26").
Q4 organic growth vs. the ~7.6% implied bar given the tough First Aid/Uniform Direct comps — a beat here reassures on underlying demand despite soft employment.
Margin sustainability (>50% gross margin, ~28–30% incrementals) and buyback resumption timing.

Net: the fundamentals point to another solid, likely beat-and-slightly-raise Q4, but this is unusually a guidance-and-deal event more than a results event — the FY27 outlook and UniFirst framing will set the tone.

Sources: Cintas FQ1–FQ4'25 and FQ1–FQ3'26 earnings releases and the FQ3'26 earnings call transcript; UniFirst merger announcement (March 11, 2026); market prices through July 14, 2026. Figures labeled "implied" are derived from company guidance less reported year-to-date results, not company-stated quarterly targets. This is informational analysis, not investment advice.